Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (1-10 of 386) with videos related to

Pageof 39
Sort By:
Cell Cycle (Georgetown, Tex.)|August 3, 2010
HDAC inhibitors repress the polycomb protein BMI1Steven Grant
Cell Cycle (Georgetown, Tex.)|August 18, 2009
CDK inhibitors and immune responsesSteven Grant
British Journal of Nursing (Mark Allen Publishing)|February 28, 2019
Limitations of track and trigger systems and the National Early Warning Score. Part 3: cultural and behavioural factorsSteven Grant
Advances in Cancer Research|October 24, 2012
PrefaceSteven Grant
Leukemia & Lymphoma|August 26, 2017
Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignanciesSteven Grant
Haematologica|May 3, 2020
Recruiting TP53 to target chronic myeloid leukemia stem cellsSteven Grant
Addiction (Abingdon, England)|December 9, 2004
Let' s not be impulsive: comments on Lubman et al. (2004)Steven Grant
Blood|September 3, 2016
Atg7 in AML: a double-edged sword?Steven Grant
Leukemia & Lymphoma|August 26, 2011
Targeting Waldenstrom macroglobulinemia with histone deacetylase inhibitorsSteven Grant
Best Practice & Research. Clinical Haematology|December 5, 2009
New agents for AML and MDSSteven Grant
Pageof 39

Showing results (1-10 of 386) with videos related to

Sort By:
Pageof 39
Cell Cycle (Georgetown, Tex.)|August 3, 2010
HDAC inhibitors repress the polycomb protein BMI1Steven Grant
Cell Cycle (Georgetown, Tex.)|August 18, 2009
CDK inhibitors and immune responsesSteven Grant
British Journal of Nursing (Mark Allen Publishing)|February 28, 2019
Limitations of track and trigger systems and the National Early Warning Score. Part 3: cultural and behavioural factorsSteven Grant
Advances in Cancer Research|October 24, 2012
PrefaceSteven Grant
Leukemia & Lymphoma|August 26, 2017
Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignanciesSteven Grant
Haematologica|May 3, 2020
Recruiting TP53 to target chronic myeloid leukemia stem cellsSteven Grant
Addiction (Abingdon, England)|December 9, 2004
Let' s not be impulsive: comments on Lubman et al. (2004)Steven Grant
Blood|September 3, 2016
Atg7 in AML: a double-edged sword?Steven Grant
Leukemia & Lymphoma|August 26, 2011
Targeting Waldenstrom macroglobulinemia with histone deacetylase inhibitorsSteven Grant
Best Practice & Research. Clinical Haematology|December 5, 2009
New agents for AML and MDSSteven Grant
Pageof 39